![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 22387-22394, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 8, 1999, and in revised form, April 12, 2000
Cardiolipin (CL) is a unique phospholipid which
is present throughout the eukaryotic kingdom and is localized in
mitochondrial membranes. Saccharomyces cerevisiae cells
containing a disruption of CRD1, the structural gene
encoding CL synthase, have no CL in mitochondrial membranes. To
elucidate the physiological role of CL, we compared mitochondrial
functions in the crd1 Cardiolipin (1,3-bis (1',
2'-diacyl-3'-phosphoryl-sn-glycerol)-sn-glycerol
(CL))1 is a structurally
unique phospholipid that carries four acyl groups and two negative
charges. It is thus highly hydrophobic and acidic. The biosynthesis of
CL occurs in three enzymatic steps (1-3).
Phosphatidylglycerolphosphate (PGP) synthase catalyzes the formation of
PGP from phosphatidyl-CMP (CDP-diacylglycerol; CDP-DG) and glycerol
3-phosphate. PGP is then dephosphorylated to phosphatidylglycerol
(PG) by PGP phosphatase. Eukaryotes and bacteria utilize different
reactions to convert PG to CL. In prokaryotes, CL synthase catalyzes a
phosphatidyl transfer between two PG molecules (4). This is a
near-equilibrium (transesterification) reaction that is mainly
controlled by substrate availability. In contrast, eukaryotic CL
synthase catalyzes a phosphatidyl transfer from CDP-DG to PG (5-7).
This is an irreversible reaction that involves cleavage of a high
energy anhydride bond. This reaction can take place in the presence of
low substrate concentration and is mainly regulated by CL synthase
activity. The differences in these reactions probably reflect different
functions of PG and CL in prokaryotes and mitochondria.
In Escherichia coli, the enzymes that catalyze the synthesis
of CL have been characterized biochemically, and the genes encoding these enzymes have been cloned. Although disruption of the
cls gene (encoding CL synthase) is not lethal, bacterial
strains bearing a null allele of pgsA (encoding PGP
synthase) are inviable (8, 9). Interestingly, bacterial cls
null mutants do synthesize CL, presumably by another enzyme. These
experiments suggest that the anionic phospholipids PG and/or CL are
essential for bacterial viability.
In eukaryotic cells, CL is found primarily in mitochondrial membranes
(10). Because of its acidic and hydrophobic nature, CL has the ability
to interact with many different proteins (10, 11). It is associated
with the major proteins of oxidative phosphorylation, including complex
V (ATP synthase), respiratory complexes I, III, and IV, as well as the
carrier proteins for phosphate and adenine nucleotides (12-17).
Trivedi et al. (18) showed that a temperature-sensitive yeast mutant that had reduced CL at the elevated temperature had a
concomitant decrease in cytochrome oxidase activity. In
vitro experiments suggest that mitochondrial inner membrane
integrity may depend specifically on CL, because enzymatic digestion of CL, but not PE or PC, correlates with the disruption of structure (19).
Evidence also suggests that CL may be required for import of proteins
into the mitochondria, because doxorubicin (which binds irreversibly to
CL) inhibits protein import (20, 21).
Despite the obvious importance of CL, in vivo experiments to
elucidate the role of this lipid and the mechanisms of its regulation have not been previously possible, because of the lack of a model system in which CL levels could be genetically manipulated. The molecular tools are now available to carry out these experiments in the
yeast Saccharomyces cerevisiae. We identified the S. cerevisiae structural gene encoding CL synthase (CRD1,
originally named CLS1) and showed that disruption of the
CRD1 gene eliminates CL from mitochondrial membranes (22).
These findings were confirmed by Tuller et al. (23) and
Chang et al. (24). Growth of the crd1 DNA Manipulations--
Plasmid purification from E. coli was performed using the Wizard Plus Miniprep DNA Purification
system (Promega, Madison, MI). CRD1 fragments were generated
by polymerase chain reaction and ligated into the expression vector
pYES2.0 as described (26). Transformations of E. coli cells
were performed using an electro cell manipulator at 2.45 kV.
Yeast Genetic Techniques--
S. cerevisiae strains
used in this work are listed in Table I.
Complex media for liquid cultures used in all experiments except
measurement of ADP/ATP carrier (AAC) (see Table IV) contained 1% Bacto
yeast extract and 2% Bacto peptone (Difco Laboratories, Detroit, MI),
with 2% glucose (YPD), 2% galactose, 2% raffinose (YPR), 3%
glycerol (YPG), or 3% glycerol plus 0.95% ethanol (YPGE) as carbon
source. Complex media for experiments to measure AAC (Table
IV) contained 0.3% yeast extract, 0.05%
peptone, 2% lactate, and 0.1% glucose. Synthetic medium was prepared
as described previously (27). Solid medium contained 2% agar in
addition to the above. Yeast transformations were performed with an
electro cell manipulator (BTX, San Diego, CA) as described previously
(22), and transformants were selected on synthetic medium lacking
specific nutrients as required.
Induction of Viable Cell Determination--
Yeast cells from a 20-ml
preculture in the logarithmic phase of growth were resuspended in 200 ml of prewarmed YPD or YPGE medium. Cultures were incubated with
continuous agitation for 6-7 days. Aliquots were serially diluted,
spread on YPD plates, and incubated at 30 °C until colonies formed.
Isolation of Mitochondria--
Intact mitochondria were isolated
as described by Daum et al. (29) using 2.5 mg of Zymolyase
20T (ICN Biomedicals, Aurora, OH)/gram of cells to form spheroplasts.
The extent of spheroplast formation was monitored with a
spectrophotometer. The reaction was terminated when a 1:100
water-diluted reaction mixture reached an A600
of about 20% of the starting value. Alternatively, when integrity of
mitochondria was not required, mitochondria were isolated using the
glass bead method as described earlier and purified by differential
centrifugation (27).
Analysis of Total Mitochondrial Phospholipids--
Mitochondria
were isolated as described above and resuspended in isolation buffer at
a protein concentration of 5 mg/ml. Total mitochondrial phospholipids
were extracted and purified as described (30). Briefly, the
mitochondrial suspension was extracted twice with 20 volumes of
chloroform/methanol (2:1). The extract was then washed sequentially
with 0.2 volumes of 0.9% NaCl and water, followed by low speed
centrifugation. The organic phase was transferred to a glass tube,
dried under a nitrogen current, and resuspended in 150 µl of
chloroform:methanol (2:1). Isolated total phospholipids were then
applied to silica gel 60 plates (EM Separations Technology, Gibbstown,
NJ), which were developed with chloroform/methanol/25% ammonium
hydroxide (65:35:5) in the first dimension and
chloroform/acetone/methanol/acetic acid/water (50:20:10:10:5) in the
second dimension. The developed TLC plates were dried and exposed to
iodine vapor to visualize the phospholipid spots, which were labeled
with a pencil and subjected to sulfuric acid combustion and phosphorus
quantitation as described (31). The relative percentage of phosphorus
in the individual phospholipid species is presented as a percentage of
the total phospholipid phosphorus.
Assays of Mitochondrial Enzyme Activity and Content--
Yeast
cells were grown in fermentable or nonfermentable medium with
agitation. Mitochondria were isolated from cells harvested at the early
stationary growth stage. Mitochondrial ATPase and cytochrome oxidase
were assayed as described (32, 33). The isolation of AAC from
mitochondria and the reconstitution into phospholipid vesicles were
performed as described (34). The exchange rates were measured according
to the rapid mixing and removal procedure and evaluated to a first
order rate law using a computerized program. As a control, inhibition
by prior addition of 5 µM bongkrekate (BKA) and 10 µM carboxyatractylate (CAT) was determined.
The AAC content in mitochondria was determined by the competitive
enzyme-linked immunosorbent assay as described previously (35).
Measurements of [3H]CAT binding to mitochondria were
performed as described (35).
Measurement of Respiration and Oxidative Phosphorylation--
To
determine the maximum respiratory rate, yeast cells were grown to early
stationary phase, and intact mitochondria were isolated. The
mitochondria were resuspended in buffer containing 0.6 M
sucrose, 10 mM KH2PO4, 12 mM EDTA, 10 mM Tris-HCl, pH 7.4, 2 mg/ml BSA at
a final protein concentration of 0.5 mg/ml. Respiratory rate was
measured at 25 °C as described (36), using 2.5 mM
glutamate/malate or 5 mM succinate as substrate. Oxygen
consumption was monitored with a Clark oxygen electrode (Yellow Springs
Instrument Co., Yellow Springs, OH) while the mitochondrial suspension
was gently stirred.
To measure oxidative phosphorylation, isolated mitochondria were
suspended at 1 mg of protein/ml in 2.0 ml of a medium containing 0.25 M sucrose, 20 mM KCl, 20 mM
Tris-HCl, 0.5 mM EDTA, 10 mM glucose, 4 mM NaPO4, and 3 mM
MgCl2 at pH 7.2. Further additives were 0.5 mg of BSA, 10 µM AP5S, 50 µM ADP, and 3 units/ml hexokinase. The suspension was aerated with O2 for
2-3 min at 25 °C. The "zero sample" was withdrawn, and the
oxidative phosphorylation was started by the addition of 5 mM L- Import Assay--
Mitochondria were isolated from yeast cells
grown in YPG or YPD according to Daum et al. (29) and Hartl
et al. (37). Radiolabeled preproteins were obtained by
in vitro transcription and translation reactions using
rabbit reticulocyte lysate (Amersham Pharmacia Biotech) in the presence
of [35S]methionine/cysteine (38).
Mitochondrial in vitro import reactions were performed in
BSA-containing buffer (3% (w/v) fatty acid-free BSA, 80 mM
KCl, 5 mM MgCl2, 10 mM MOPS/KOH, pH
7.2) in the presence of 2 mM ATP and 2 mM NADH.
To dissipate the membrane potential, 8 µM antimycin A, 20 µM oligomycin, and 1 µM valinomycin (Sigma)
were added to the import reaction. Reticulocyte lysate containing
radiolabeled preproteins (2.5% (v/v) of import reaction) was incubated
with mitochondria (25-50 µg of protein) at 25 °C for varying
times. Where indicated, mitochondria in BSA-containing buffer were
first incubated at 37 °C for 15 min prior to import at 25 °C.
Valinomycin (1 µM) was added to stop import, and samples
were subsequently treated with proteinase K (50 µg/ml) on ice for 15 min. The protease was inactivated by the addition of 1 mM
phenylmethylsulfonyl fluoride, and samples were incubated for a further
10 min at 4 °C before SDS-PAGE analysis.
Mitochondrial Membrane Potential Determination--
The Protein Gel Electrophoresis--
SDS-PAGE was performed on
10 × 7 cm slab minigels with a thickness of 0.75 mm at an
acrylamide concentration of 12.5%. The electrophoresis was carried out
using the procedure described by Laemmli (41). Blue native gel
electrophoresis of mitochondrial samples solubilized in
digitonin-containing buffer (1% (w/v) digitonin, 20 mM
Tris-HCl, pH 7.4, 0.1 mM EDTA, 50 mM NaCl, 10%
(v/v) glycerol, 1 mM phenylmethylsulfonyl fluoride) (42),
and immunoblotting was performed according to Dekker et al.
(43). Two-dimensional gel electrophoresis of total mitochondrial
proteins was carried out according to O'Farrell et al.
(44), with isoelectric focusing as the first dimension and SDS-PAGE as
the second. All gels were stained with either Coomassie Brilliant Blue
R-250 or silver stain (Bio-Rad).
Protein Assay--
Protein concentration was determined by the
method of Bradford (45) with BSA as the standard. Buffers identical to
those containing the protein samples were used as blanks.
The crd1
In summary, these experiments indicate that the crd1 The crd1
Crd1 Protein Import Is Partially Defective in the crd1
The import of both preproteins into crd1
To assess whether the import defect observed in vitro
affected the steady state mitochondrial protein profile, we carried out
one- and two-dimensional gel electrophoresis of total mitochondrial proteins. No obvious changes were observed in cells grown in YPD or
YPGE medium, indicating that the observed import defect was probably
not severe enough to affect the steady state protein level at 30 °C
(data not shown).
The crd1 Respiratory Enzyme Activity and Maximum Respiration Rate Are
Decreased in the crd1 Oxidative Phosphorylation and AAC Activity Are Decreased in the
crd1
AAC was isolated from the mitochondria and reconstituted into
phospholipid vesicles to determine the actual transport rates (34). For
this purpose, the "basic" ADP/ADP exchange was measured, because it
is the most indifferent to
AAC exists as a dimer of 34.5-kDa subunits (49). When mitochondria are
solubilized in digitonin-containing buffer and are subjected to blue
native PAGE), wild type AAC is predominantly found at a position of
~80 kDa (50). The position of native AAC on this PAGE system may
reflect phospholipid molecules that are still tightly bound to the AAC
dimer. Indeed when mitochondria lacking CL were subjected to blue
native PAGE and probed with AAC antibodies, it was found that AAC
showed a slight but significant increase in its mobility (Fig.
4, lanes 2 and 4)
compared with wild type mitochondria (Fig. 4, lanes 1 and
3). This change correlates well with the absence of bound CL
molecules in the mutant protein. The mobility of AAC was affected in
mutant mitochondria containing or lacking PG. Additionally, larger AAC
oligomers of low abundance were visible in wild type but not in
crd1 Numerous in vitro experiments have pointed to the
importance of CL in cellular and mitochondrial function (reviewed in
Ref. 10). The availability of a yeast mutant that cannot synthesize CL
provides us with an experimental vehicle to ascertain the role of this
lipid. We previously cloned the CRD1 gene encoding CL synthase and constructed a null mutant that contains no CL in its
membranes (22). In this study, we compared cellular and mitochondrial
functions in the crd1 null mutant and isogenic wild type
strains and conclude the following: 1) The lack of CL in mitochondrial
membranes is associated with pleiotropic defects in mitochondrial
function, including mitochondrial enzyme activities, maximum
respiration rate, oxidative phosphorylation, and protein import. The
defects were less apparent in conditions under which mitochondrial
membranes contained PG, suggesting that PG can compensate for lack of
CL in some, but not all, cellular functions. 2) Mitochondria lacking CL
have a significantly decreased membrane potential. The decrease is less
pronounced when the membranes contain PG. 3) At elevated temperatures,
CL is required for (an) essential cellular function(s) and for
maintenance of mitochondrial DNA.
Previous studies showed that crd1 The decrease in the rate of protein import correlates with a decreased
membrane potential in CL-lacking mitochondria, suggesting that one or
more components of the respiratory complexes or inner membrane
transporters is impaired. Indeed, the activities of cytochrome oxidase
and the AAC were reduced in crd1 Viewed in the background of these results, it is not surprising that
oxidative phosphorylation is strongly reduced in the mitochondria from
CL-deficient cells. This oxidative phosphorylation activity was
entirely dependent on the ADP/ATP exchange by the AAC, as shown by the
inhibition with BKA and CAT. Respiration is less affected by CL
deficiency, probably in line with the lower dependence of the
respiratory components on CL. Interestingly, the content of AAC in the
deficient mitochondria appears not to be affected, indicating that the
AAC present is largely inactivated. The distinct residual activity of
the AAC in these mitochondria suggests that the endogenous high content
of acidic phospholipids can replace CL to some extent, in contrast to
the in vitro situation with reconstituted AAC (55). It seems
that, in vivo, AAC is somehow better adapted by subtle
rearrangements to the high content of acidic PG, which thus allows for
a minimum transport activity. After isolation and reconstitution, the
AAC from CL-deficient mitochondria has virtually an absolute dependence
on CL. Addition of PG instead of CL did not enhance activity.
A key finding in this study is that the mitochondrial inner membrane
lacking acidic phospholipids PG and CL has a reduced membrane
potential. The decrease is less pronounced in membranes containing PG
than in membranes lacking both PG and CL (Fig. 3). The lack of CL may
impair the generation of a proton gradient across the inner membrane
(by inhibition of the activity of respiratory chain complexes), and/or
the maintenance of a proton gradient (by affecting the membrane barrier
either directly or via impairment of inner membrane carrier proteins).
Either defect may result in a reduction of Why is there no detectable PG in mitochondria from glucose-grown
crd1 The loss of viability of the crd1 We thank Vasilij Koshkin and Diego Rua for
helpful discussions, Günther Daum for yeast strains, Lee Aggison
and Hanne Müller for technical assistance, and Nils Wiedemann and
Asimur Rahman for help in preparing the figures.
*
This work was supported by a grant from the Deutsche
Forschungsgemeinschaft (to M. K.), grants from the Deutsche
Forschungsgemeinschaft, Sonderforschungsbereich 388 Freiburg and the
Fonds der Chemischen Industrie (to N. P.), and a grant from the
Barbara Ann Karmanos Cancer Institute and National Institutes of Health
Grant HL62263 (to M. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
Published, JBC Papers in Press, April 20, 2000, DOI 10.1074/jbc.M909868199
The abbreviations used are:
CL, cardiolipin;
PG, phosphatidylglycerol;
PGP, phosphatidylglycerolphosphate;
AAC, ADP/ATP carrier;
YPD, yeast
extract-peptone-dextrose;
YPG, yeast extract-peptone-glycerol;
YPGE, yeast extract-peptone-glycerol-ethanol;
BKA, bongkrekate;
CAT, carboxyatractylate;
BSA, bovine serum albumin;
MOPS, 4-morpholinepropanesulfonic acid;
PAGE, polyacrylamide gel
electrophoresis.
Absence of Cardiolipin in the crd1 Null Mutant
Results in Decreased Mitochondrial Membrane Potential and Reduced
Mitochondrial Function*
§,
,
,
,

Department of Biological Sciences, Wayne
State University, Detroit, Michigan 48202, the ¶ Institut
für Biochemie und Molekularbiologie, Universität Freiburg,
D-79104 Freiburg, Germany, the
Department of Anesthesiology,
Hospital for Special Surgery, New York, New York 10021, and the
** Institut für Physikalische Biochemie, Universität
München, 80336 Munich, Germany
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
mutant and isogenic wild type. The
crd1
mutant loses viability at elevated temperature, and
prolonged culture at 37 °C leads to loss of the mitochondrial
genome. Mutant membranes have increased phosphatidylglycerol (PG) when
grown in a nonfermentable carbon source but have almost no detectable
PG in medium containing glucose. In glucose-grown cells, maximum
respiratory rate, ATPase and cytochrome oxidase activities, and protein
import are deficient in the mutant. The ADP/ATP carrier is defective
even during growth in a nonfermentable carbon source. The mitochondrial
membrane potential is decreased in mutant cells. The decrease is more
pronounced in glucose-grown cells, which lack PG, but is also apparent
in membranes containing PG (i.e. in nonfermentable carbon
sources). We propose that CL is required for maintaining the
mitochondrial membrane potential and that reduced membrane potential in
the absence of CL leads to defects in protein import and other
mitochondrial functions.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
mutant
in glucose or nonfermentable carbon sources is largely unaffected at
30 °C; however, at elevated temperature, the mutant loses viability,
even in glucose (25). Expression of CRD1 is highly regulated
by factors affecting mitochondrial development, including carbon
source, growth stage, and the presence of a mitochondrial genome (25).
These results point to the involvement of CL in critical cellular
functions. In this paper, we investigated the role of CL in
mitochondrial function by characterizing the physiological effects of
eliminating CL from the membrane.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Yeast strains used in this work
Mitochondrial phospholipid composition during growth in YPD and
YPGE
0 mutants was carried out using
ethidium bromide treatment as described (28). Haploid cells were
cultured for 48 h in the presence of 25 µg/ml ethidium bromide
in minimal medium containing 2% glucose, 0.2% ammonium sulfate, 0.69 mg/ml vitamin-free yeast base and required nutrients. Cells that formed
colonies on YPD but not YPGE plates were selected. Putative
0 mutants were crossed to several

mutants bearing mitochondrial DNA lesions
oxi1, oxi2, oxi3, or cob.
After overnight growth on YPD plates at 30 °C, the diploids were
replicated to solid YPGE medium. The absence of a mitochondrial genome
in the induced petite mutants was indicated by the inability of the
diploids to grow on YPGE medium.
-glycerophosphate and 50 mM
ethanol. As a control value for AAC-dependent oxidative
phosphorylation, one aliquot of 0.5 ml was withdrawn and incubated with
20 µM CAT and 10 µM BKA prior to the
addition of the substrates. This sample was then also incubated with
oxygen, and oxidative phosphorylation was started with the substrates.
After 2 min, the reaction was quenched by HClO4. From the
main suspension, aliquots of 0.25 ml were withdrawn and injected into
0.02 ml of 45% HClO4 at the following time intervals: wild
type mitochondria at 10, 20, 40, 60, and 120 s and mutant
mitochondria at 0.5, 1, 2, 4, 8, and 12 min. After neutralization with
KOH and removal of KClO4 by centrifugation, ATP was assayed
by the hexokinase-glucose-6-phosphate-dehydrogenase system. The initial
phosphorylation rate VATP was calculated from the increase of ATP content. For obtaining the
AAC-dependent rate, VATPcorrected, a correction
factor was calculated from the ATP content with and without CAT + BKA
taken 2 min after the start, according to the formula
VATPcorrected = VATP(1
[ATP(+BKA)]/[ATP]), where
VATP is the total rate without inhibitor, and
[ATP] and [ATP (+BKA)] are the amount of ATP found without and with
BKA 150 s after start of oxidative phosphorylation, respectively.

of isolated yeast mitochondria was determined by recording the
fluorescence decrease of the voltage-sensitive dye
3,3'-dipropylthiadicarbocyanine iodide (Molecular Probes Inc., Eugene,
OR) as described previously (39). The method is based on the
potential-dependent partitioning of the dye between
mitochondria and the medium, leading to a decrease in fluorescence with
increasing 
(40). The addition of mitochondria results in some
quenching of the fluorescent dye, and the 
is assessed by
comparing the fluorescence observed after addition of mitochondria and
the fluorescence observed after the 
is dissipated by the
addition of the uncouplers valinomycin and KCN. Mitochondria possessing
a higher 
have a greater uptake of the dye, resulting in a lower
fluorescence. An aliquot of 25 µg of mitochondria was used per assay.
Assays were performed at a temperature of 25 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Mutant Has Aberrant Composition of Acidic Phospholipids
in Its Mitochondrial Membranes--
Previous results indicating that
the crd1
mutant lacked CL were based on TLC analysis of
mitochondrial membrane phospholipids (22-24). More recently, utilizing
a technique specific for detection of CL, i.e. HPLC analysis
of CL derivatives, to detect CL in the null mutant (46), we observed no
detectable CL in all conditions tested (data not shown). We also
compared mutant and isogenic strains in fermentable (YPD) and
nonfermentable (YPGE) medium. (In fermentable medium, many
mitochondrial functions such as respiration are not required.)
Interestingly, when cells were grown in YPGE, the crd1
mutant FGY2 had significantly increased PG in its mitochondrial membranes, which accounted for about 10% of total phospholipid phosphorus (Table II). Under these growth conditions, the wild type CL
content is approximately 12% of phospholipid phosphorus. In striking
contrast, no increase in PG was observed in mutant cells grown in YPD.
Throughout the logarithmic phase of growth, PG levels in the mutant
mitochondrial membranes remained nearly undetectable (data not shown).
PG content increased only slightly as the mutant cells entered the
stationary phase of growth, accounting for about 1% of total
phospholipid phosphorus in the mitochondria. CL content in wild type
cells in this growth condition was approximately 8%. Levels of other
major phospholipids, including phosphatidic acid, remained largely
unaltered in the mutant.
mutant FGY2 is completely lacking in CL. During growth in YPGE, the mutant membrane contains 10% PG, slightly less acidic phospholipid than the wild type (12% CL). However, during growth in YPD, the mutant
has almost no acidic phospholipid, whereas the wild type has 8% CL.
These data predict that functions dependent upon acidic mitochondrial
phospholipids PG and CL are defective in the mutant, and the defects
may be more apparent during growth in glucose than in nonfermentable
carbon sources.
Mutant Loses Viability during Growth at Elevated
Temperature--
When cells of the crd1
mutant are
patched onto plates and incubated at 37 °C, the mutant exhibits no
apparent growth defect. However, we have shown that the
crd1
mutant strain FGY2 could not form colonies at
37 °C from single cells seeded on YPD or YPGE plates (25).
Crd1
mutants in two other strain backgrounds, including
the one described by Tuller et al. (23), also exhibit the
inability to form colonies at 37 °C (data not shown). To further elucidate the effect of the crd1 allele on growth at the
elevated temperature, we compared the viability of cells grown at 30 and 37 °C. At 30 °C, no decrease in viability was observed in the mutant grown in YPGE, and only a slight decrease in viability was
observed in mutant cells entering stationary phase in YPD (Fig.
1). In contrast, at 37 °C, the mutant
cells had significantly decreased viability compared with the wild type
in both YPD and YPGE medium.

View larger version (15K):
[in a new window]
Fig. 1.
The crd1
mutant FGY2 is temperature-sensitive. Prewarmed
liquid YPD or YPGE medium were inoculated with cells from wild type
(FGY3, triangles) or crd1
(FGY2,
circles) strains and incubated at 30 °C or 37 °C with
agitation. The number of viable cells was determined by serial dilution
and plating on YPD plates as described under "Experimental
Procedures."
mutant cells grown in YPD or YPGE segregated large
numbers of petites (respiratory incompetent cells) after prolonged culture at elevated temperature (data not shown). Diploids formed by
mating the crd1
petites with a
0 mutant (which lacks mitochondrial DNA) were
incapable of growing on glycerol plates, indicating that the petite
phenotype was caused by cytoplasmic mutation (loss of mitochondrial
DNA). The crd1
petite mutants could not complement
oxi1, oxi2, oxi3, or cob
mutants, which contain mutations in mitochondrial genes, for growth on glycerol, suggesting that they were very likely
0 mutants. The crd1
petites had
a temperature sensitivity phenotype similar to the parent
crd1 FGY2 strain on glucose plates, in contrast to an
isogenic CRD1
0 mutant (data not shown).
These data indicate that the crd1
allele leads to loss of
viability and loss of mitochondrial DNA during growth at elevated
temperatures, in both fermentable and nonfermentable carbon sources.
Mutant--
To determine whether mitochondria lacking CL exhibited
preprotein import defects, mitochondria were isolated from both wild type and crd1
mutant cells grown in both nonfermentable
(YPG) or fermentable (YPD) medium and then subjected to in
vitro import analysis. Two preproteins were employed: the
precursor of the
subunit of the F1-ATPase
(F1
) that is targeted to the matrix face of the inner
membrane and a preprotein consisting of the presequence of
Fo-ATPase subunit 9 fused to dihydrofolate reductase (Su9-DHFR) that is targeted to the matrix. The preproteins were synthesized in vitro in rabbit reticulocyte lysate in the
presence of [35S]methionine/cysteine and incubated with
isolated yeast wild type or crd1
mitochondria at 25 °C
for increasing times. Following import, samples were treated with
proteinase K to remove nonimported preprotein. In the presence of a
membrane potential, 
, across the inner membrane, the preproteins
were transported to a protease-protected location (Fig.
2, A and B,
lanes 1-4 and 6-9). Upon dissipation of the

, import was blocked (Fig. 2, A and B,
lanes 5 and 10).

View larger version (25K):
[in a new window]
Fig. 2.
crd1
mitochondria have a
partial defect in preprotein import efficiency. Mitochondria were
isolated from wild type (WT) and crd1
cells
grown in YPG (A) or YPD (B) medium and subjected
to preprotein import analysis (A and B) in the
presence (lanes 1-4 and 6-9) or absence
(lanes 5 and 10) of 
. Following import at
25 °C, samples were treated with proteinase K prior to SDS-PAGE and
phosphorimage analysis. Imported preprotein was quantified where 100%
represents the amount of preprotein imported in wild type mitochondria
after 15 min (A and B, lower
panels).
mitochondria was
inhibited by 40-60% compared with wild type mitochondria when the cells were grown on YPD medium (Fig. 2B). The import of the
preproteins was only slightly reduced when the cells were grown on YPG
(Fig. 2A).
Mutant Has Decreased Mitochondrial Membrane
Potential--
The import inhibition in crd1
mitochondria from YPD-grown cells was greater for the F1
preprotein than for Su9-DHFR. It was previously shown that the import
of F1
shows a stronger dependence on the mitochondrial membrane
potential, 
, than that of Su9-DHFR (47). We thus wondered whether
the decrease in import in CL-lacking mitochondria was due to a lower

. We assayed the 
of wild type mitochondria and
crd1
mitochondria using the fluorescent dye,
3,3'-dipropylthiadicarbocyanine iodide. As shown (Fig.
3), mitochondria lacking CL possessed a
decreased 
(higher fluorescence) in comparison with wild type
mitochondria from cells grown in either YPG or YPD preparations.
Moreover, this decreased 
was more pronounced in mutant
mitochondria isolated from cells grown in YPD medium. These results
suggest that the decrease in 
is the likely explanation for the
partial inhibition of protein import.

View larger version (30K):
[in a new window]
Fig. 3.
crd1
mitochondria have a
reduced membrane potential. The 
of mitochondria
(Mito.) isolated from wild type and crd1
cells
grown in YPG (A) or YPD (B) medium was assayed
using the potential-sensitive dye 3,3'-dipropylthiadicarbocyanine
iodide. A more pronounced fluorescence quenching (decrease) after
addition of mitochondria indicates a higher 
, whereas the
addition of 1 µM valinomycin (Val.)/1
mM KCN dissipates 
.
Mutant in YPD--
Cytochrome c
oxidase catalyzes the last step of the respiratory chain, the transfer
of four electrons to molecular oxygen. As a result, proton and ion
gradients are generated across the mitochondrial inner membrane, which
drive the ATPase reaction. These reactions play a key role in energy
production. In vitro studies have shown that ATPase and
cytochrome oxidase activities are strongly CL-dependent. We
investigated the effect of the crd1
mutation on in
vivo activities of these enzymes. As shown in Table III, when cells were grown in YPGE, no
differences between the mutant and wild type ATPase or cytochrome
c oxidase activities were observed. In contrast, when cells
were grown in YPD, activities of both enzymes were significantly
decreased in the mutant mitochondria compared with those of the
isogenic wild type. The mutant exhibited a corresponding decrease in
respiration. As shown in Table III, mitochondria from mutant cells
grown in YPD had a significantly decreased maximum respiratory rate in
comparison with the wild type. No such difference was observed for
mitochondria isolated from cells grown in YPGE. These data show that in
the absence of both PG and CL, respiration is defective. However, it is
likely that PG can substitute for CL to some extent, because the
maximum respiratory rate in YPGE is not reduced in the mutant.
ATPase, cytochrome oxidase, and maximum respiration rate are decreased
in the crd1
mutant
Mutant--
To further characterize the respiratory capacity
of crd1
mutant mitochondria, oxidative phosphorylation
was measured in the presence of the more active substrates
-glycerol
phosphate and ethanol (Table IV). Cells
were grown in the nonfermentable carbon source lactate, which, like
glycerol/ethanol, is derepressing for PG (23) and is the carbon source
used in previous experiments characterizing the ADP/ATP carrier
(34-35). Oxidative phosphorylation activity of isolated mitochondria
was measured directly by the rate of ATP synthesis from added ADP (35).
The ATP synthesis was started by initiating electron transport upon
addition of
-glycerol phosphate. The time progress of ATP formation
was determined in samples withdrawn at increasing time intervals. The
rates of oxidative phosphorylation are given in Table IV. Oxidative
phosphorylation is strongly decreased in the CL-deficient mitochondria.
The rates in the mutant are only about 20% of the parent strain.
Respiration is decreased to a lesser extent. The ATP synthesis is
nearly fully blocked by the combined addition of BKA and CAT,
indicating that all the ATP passes through the AAC. The amount of AAC
contained in these mitochondria is assayed by [3H]CAT
binding (48). There is no difference between the CL-deficient and
parent strain, indicating that the amount of AAC taken up in the
mitochondria is not affected by the lack of CL but that the AAC present
is much less active.
Oxidative phosphorylation, respiration, and content and transport
activity of the AAC
mutant cells were grown in the
presence of the nonfermentable carbon source lactate. Oxidative
phosphorylation in isolated mitochondria was measured by following the
kinetics of ATP synthesis, as described under "Experimental
Procedures." AAC content was determined by the kinetics of 3H
CAT binding.

among the four exchange modes.
Vesicles were prepared with and without 8% CL. The transport activity
was evaluated from the time progress of [14C]ADP uptake.
It is clearly evident that the exchange activity is dramatically
dependent on the presence of CL. The results from two separate
reconstitution experiments are listed in Table IV. Without CL addition,
AAC from the CL-deficient yeast has virtually no activity, whereas the
AAC from the parent strain still shows a low but definite exchange.
Obviously, residual endogenous CL still enables some transport
activity. Upon CL addition, the stimulated exchange activity of the AAC
from the CL-deficient yeast reaches only half (or even less) the
activity observed in the parent strain. Presumably, the AAC from the
deficient strain remains less optimally folded, even with excess of
added CL.
mitochondria. Viewed with the decreased AAC activity
in mitochondria containing PG, the data indicate that PG cannot
substitute for CL in supporting AAC function.

View larger version (26K):
[in a new window]
Fig. 4.
Altered mobility of ADP/ATP carrier on blue
native electrophoresis in crd1
mutant. Mitochondria (50 µg) isolated from wild
type (WT) or CL-deficient (crd1
) cells grown
in either YPG or YPD medium as indicated were solubilized in digitonin
buffer prior to blue native electrophoresis and immunoblotting with
antibodies against AAC.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
mutant cells did not
exhibit severe growth defects at 30 °C in fermentable or
nonfermentable carbon sources (22-24). At least two explanations can
account for this observation. One is that, despite its unique structure
and localization, CL is largely dispensable for cellular and
mitochondrial function. Alternatively, it is possible that CL is
essential for optimal mitochondrial function, but PG can compensate to
some extent for the loss of CL. The crd1
mutant strain
FGY2 provides an ideal experimental vehicle with which to distinguish
between these possibilities. The mutant is completely lacking in CL,
and the presence of PG can be manipulated by growth conditions. Thus, mutant mitochondrial membranes contain PG in nonfermentable carbon sources, whereas in fermentable carbon sources, PG is undetectable throughout the logarithmic growth phase and only slightly detectable in
early stationary phase (Table II and data not shown). Tuller et
al. (23) also reported the absence of PG in glucose-grown crd1
mutant cells. (The growth stage in which their
phospholipid analyses were carried out was not indicated.) Controlling
PG content in this manner, we determined that, in the absence of PG,
the maximum respiration rate and activities of respiratory enzymes are
decreased in the mutant (Table III). In the presence of PG, these
activities are comparable with wild type. Thus, it appears that some
acidic phospholipid is needed for these functions and that PG can
compensate for the lack of CL. It is possible that other phospholipids
may be able to compensate for the lack of CL. Phosphatidic acid might
be a potential CL substitute, owing to its acidic nature. In
vitro studies have shown that phosphatidic acid could activate
some CL-dependent enzymes, including yeast PGP synthase
(51) and beef heart cytochrome c oxidase (52). Tuller
et al. (23) did observe an increase in phosphatidic acid in
the crd1
mutant mitochondria. However, in our strain, no
dramatic changes in phosphatidic acid level were apparent in the mutant under any condition tested. Therefore, it is more likely that PG
compensates for the lack of CL. This conclusion is further supported by
the fact that although disruption of CRD1 led to no severe
phenotypes in nonfermentable medium at 30 °C, disruption of
PGS1, the structural gene for PGP synthase, caused severe
mitochondrial dysfunction (53, 54).
mitochondria. Moreover the activity of the AAC purified from mutant cells grown in
nonfermentable medium (and thus containing PG) is reduced compared with
wild type (Table IV), indicating that not all CL-requiring functions can be fully compensated by PG. Among the mitochondrial components so
far known, the AAC has by far the strongest requirement for CL (17, 55,
56). NMR analysis of isolated bovine heart AAC indicates that six CL
molecules are tightly bound to the AAC and can only be released by
denaturation (17). Similar high CL content was found in the isolated
yeast AAC2 (55). Two additional molecules of CL can be bound loosely
but with high specificity (56). Because of the tight binding, the
dependence of bovine heart AAC transport on CL could not be shown,
because CL was carried over into the reconstituted phospholipid
vesicles. However, the yeast AAC (AAC2) has an absolute dependence on
CL addition for transport. This is particularly evident in the various
cysteine mutants in which Cys is replaced by Ser without any effect on
the transport activity (55). In AAC from these mutants, NMR
measurements indicate that the bound CL is reduced to about 2-3 mol
CL/AAC dimer. The specificity requirement for CL in the activation of
AAC in the reconstituted system was very high, and no other acidic
phospholipid could replace CL.

. Because oxidative
phosphorylation and protein import depend on the presence of a membrane
potential, it is likely that their reduced function in the
crd1
mutant can be attributed either partly or wholly to
the reduced membrane potential.
mutant cells? One possible explanation may be that PGP synthase activity is defective in the membrane. We did not detect a
difference between wild type and mutant specific activity in
glucose-grown cells (22), although Tuller et al. (23) found a 70% decrease and Chang and co-workers (24) observed a 35% decrease
in activity in glucose-grown mutant mitochondria. The variation among
these three laboratories may be due to strain differences, growth
stage, and/or growth conditions. Strain differences clearly play a role
in both PG content and temperature sensitivity, because some
crd1 null mutant strains constructed in other laboratories are not temperature-sensitive. Alternatively, the assay in
mitochondrial extracts may not reflect the true in vivo
activity. The enzyme present in the mutant membrane may be incorrectly
folded and, thus, inactive. This would be missed in enzyme assays
carried out under optimal conditions in the presence of Triton
X-100.
mutant at the elevated
temperature suggests that CL is required for some essential cellular function(s). Respiration is not essential for viability of yeast cells
during growth in glucose. Protein import is essential; however, the
observed decrease in the rate of import is probably not sufficient to
account for loss of viability. The temperature sensitivity may be
related to loss of AAC activity or to other CL-requiring activities not
yet identified. Current experiments are aimed at identifying the
essential functions that require CL.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES

To whom correspondence should be addressed. Tel.: 313-577-5202;
Fax: 313-577-6891; E-mail: MLGREEN@sun.science.wayne.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Cobon, G. S.,
Crowfoot, P. D.,
and Linnane, A. W.
(1974)
Biochem. J.
144,
265-275
2.
Steiner, M. R.,
and Lester, R. I.
(1972)
Biochim. Biophys. Acta
260,
222-243
3.
van den Bosch, H.,
van Golde, L. M. G.,
and van Deenen, L. L. M.
(1972)
Rev. Physiol. Biochem. Exp. Pharmacol.
66,
13-145
4.
Hirschberg, C. B.,
and Kennedy, E. P.
(1972)
Proc. Natl. Acad. Sci. U. S. A.
69,
648-651
5.
Hostetler, K. Y.,
van den Bosch, H.,
and van Deenen, L. L. M.
(1972)
Biochim. Biophys. Acta
260,
507-513
6.
Tamai, K. T.,
and Greenberg, M. L.
(1990)
Biochim. Biophys. Acta
1046,
214-222
7.
Schlame, M.,
Brody, S.,
and Hostetler, K. Y.
(1993)
Eur. J. Biochem.
212,
727-735
8.
Nishijima, S.,
Asami, Y.,
Uetake, N.,
Yamagoe, S.,
Ohta, A.,
and Shibuya, I.
(1988)
J. Bacteriol.
170,
775-780
9.
Heacock, P. N.,
and Dowhan, W.
(1989)
J. Biol. Chem.
264,
14972-14977
10.
Hoch, F. L.
(1992)
Biochim. Biophys. Acta
1113,
71-133
11.
Schlame, M.,
and Greenberg, M. L.
(1997)
Biochim. Biophys. Acta
1348,
201-206
12.
Fry, M.,
and Green, D. E.
(1981)
J. Biol. Chem.
256,
1874-1880
13.
Hayer-Hartl, M.,
Schagger, H.,
von Jagow, G.,
and Beyer, K.
(1992)
Eur. J. Biochem.
209,
423-430
14.
Robinson, N. C.
(1993)
J. Bioenerg. Biomembr.
25,
153-162
15.
Eble, K. S.,
Coleman, W. B.,
Hantgan, R. R.,
and Cunningham, C. C.
(1990)
J. Biol. Chem.
265,
19434-19440
16.
Kadenbach, B.,
Mende, P.,
Kolbe, H. V. J.,
Stipani, I.,
and Palmieri, F.
(1982)
FEBS Lett.
139,
109-112
17.
Beyer, K.,
and Klingenberg, M.
(1985)
Biochem.
24,
3821-3826
18.
Trivedi, A.,
Wearring, A. V.,
Kohlwein, S. D.,
Paltauf, F.,
and Tustanoff, E. R.
(1988)
in
Integration of Mitochondrial Function
(Lemasters, J. J.
, Hackenbrock, C. R.
, Thurman, R. G.
, and Weterhoff, H. V., eds)
, pp. 87-94, Plenum Publishing, New York
19.
Awasthi, T. Y.,
Berezney, R.,
Ruzicka, F. J.,
and Crane, F. L.
(1969)
Biochim. Biophys. Acta
189,
457-460
20.
Eilers, M.,
Endo, T.,
and Schatz, G.
(1989)
J. Biol. Chem.
264,
2945-2950
21.
Endo, T.,
Eilers, M.,
and Schatz, G.
(1989)
J. Biol. Chem.
264,
2951-2956
22.
Jiang, F.,
Rizavi, H. S.,
and Greenberg, M. L.
(1997)
Mol. Microbiol.
26,
481-489
23.
Tuller, G.,
Hrastnik, C.,
Achleitner, G.,
Schiefthaler, U.,
Klein, F.,
and Daum, G.
(1998)
FEBS Lett.
421,
15-18
24.
Chang, S.-C.,
Heacock, P. N.,
Mileykovskaya, E.,
Voelker, D. R.,
and Dowhan, W.
(1998)
J. Biol. Chem.
273,
14933-14941
25.
Jiang, F.,
Gu, Z.,
Granger, J.,
and Greenberg, M. L.
(1999)
Mol. Microbiol.
31,
373-379
26.
Sambrook, F.,
Fritsch, E. P.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
27.
Greenberg, M. L.,
Hubbell, S.,
and Lam, C.
(1988)
Mol. Cell. Biol.
8,
4773-4779
28.
Goldring, E. S.,
Grossman, L. I.,
Krupnick, D.,
Cryer, D. R.,
and Marmur, J.
(1970)
J. Mol. Biol.
52,
323-335
29.
Daum, G.,
Boehni, P. C.,
and Schatz, G.
(1982)
J. Biol. Chem.
257,
13028-13033
30.
Christiansen, K.,
and Jensen, P. K.
(1972)
Biochim. Biophys. Acta
260,
449-459
31.
Bartlett, G. R.
(1959)
J. Biol. Chem.
234,
466-468
32.
Tzagoloff, A.,
Akai, A.,
and Needleman, R. B.
(1975)
J. Bacteriol.
122,
826-831
33.
Tzagoloff, A.,
Akai, A.,
Needleman, R. B.,
and Zulch, G.
(1975)
J. Biol. Chem.
250,
8236-8242
34.
Heidkämper, D.,
Müller, V.,
Nelson, D. R.,
and Klingenberg, M.
(1996)
Biochem.
35,
16144-16152
35.
Müller, V.,
Basset, G.,
Nelson, D. R.,
and Klingenberg, M.
(1996)
Biochem.
35,
16132-16143
36.
Yaffe, M. P.
(1991)
Methods Enzymol.
194,
627-643
37.
Hartl, F. U.,
Ostermann, J.,
Guiard, B.,
and Neupert, W.
(1987)
Cell
51,
1027-1037
38.
Söllner, T.,
Rassow, J.,
and Pfanner, N.
(1991)
Methods Cell Biol.
3,
345-358
39.
Gärtner, F.,
Voos, W.,
Querol, A.,
Miller, B. R.,
Craig, E. A.,
Cumsky, M. G.,
and Pfanner, N.
(1995)
J. Biol. Chem.
270,
3788-3795
40.
Sims, P. J.,
Waggoner, A. S.,
Wang, C.-H.,
and Hoffman, J. F.
(1974)
Biochemistry
13,
3315-3330
41.
Laemmli, U. K.
(1970)
Nature
227,
680-685
42.
Blom, J.,
Dekker, P. J. T.,
and Meijer, M.
(1995)
Eur. J. Biochem.
232,
309-314
43.
Dekker, P. J. T.,
Martin, F.,
Maarse, A. C.,
Bömer, U.,
Müller, H.,
Guiard, B.,
Meijer, M.,
Rassow, J.,
and Pfanner, N.
(1997)
EMBO J.
16,
5408-5419
44.
O'Farrell, P. Z.,
Goodman, H. M.,
and O'Farrell, P. H.
(1977)
Cell
12,
1133-1141
45.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
46.
Schlame, M.,
Shanske, S.,
Doty, S.,
Konig, T.,
Sculco, S.,
DiMauro, S.,
and Blanck, T. J. J.
(1999)
J. Lipid. Res.
40,
1585-1592
47.
Martin, J.,
Mahlke, K.,
and Pfanner, N.
(1991)
J. Biol. Chem.
266,
18051-18057
48.
Klingenberg, M.,
Grebe, K.,
and Scherer, B.
(1975)
Eur. J. Biochem.
52,
351-363
49.
Lawson, J. E.,
and Douglas, M. G.
(1988)
J. Biol. Chem.
263,
14812-14818
50.
Ryan, M. T.,
Müller, H.,
and Pfanner, N.
(1999)
J. Biol. Chem.
274,
20619-20627
51.
Jiang, F.,
Kelly, B. L.,
Hagopian, K.,
and Greenberg, M. L.
(1998)
J. Biol. Chem.
273,
4681-4688
52.
Goormaghtigh, E.,
Brasseur, R.,
and Ruysschaert, J.-M.
(1982)
Biochem. Biophys. Res. Commun.
104,
314-320
53.
Subik, J.
(1974)
FEBS Lett.
421,
309-312
54.
Chang, S.-C.,
Heacock, P. N.,
Clancey, C. J.,
and Dowhan, W.
(1998)
J. Biol. Chem.
273,
9829-9836
55.
Hoffmann, B.,
Stockl, A.,
Schlame, M.,
Beyer, K.,
and Klingenberg, M.
(1994)
J. Biol. Chem.
269,
1940-1944
56.
Drees, M.,
and Beyer, K.
(1988)
Biochemistry
27,
8584-8591
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Chen, M. Tarsio, P. M. Kane, and M. L. Greenberg Cardiolipin Mediates Cross-Talk between Mitochondria and the Vacuole Mol. Biol. Cell, December 1, 2008; 19(12): 5047 - 5058. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Claypool, P. Boontheung, J. M. McCaffery, J. A. Loo, and C. M. Koehler The Cardiolipin Transacylase, Tafazzin, Associates with Two Distinct Respiratory Components Providing Insight into Barth Syndrome Mol. Biol. Cell, December 1, 2008; 19(12): 5143 - 5155. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Khalifat, N. Puff, S. Bonneau, J.-B. Fournier, and M. I. Angelova Membrane Deformation under Local pH Gradient: Mimicking Mitochondrial Cristae Dynamics Biophys. J., November 15, 2008; 95(10): 4924 - 4933. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Claypool, Y. Oktay, P. Boontheung, J. A. Loo, and C. M. Koehler Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane J. Cell Biol., September 9, 2008; 182(5): 937 - 950. [Abstract] [Full Text] [PDF] |
||||